Nathan Hardy
Director Financiero/CFO en SANA BIOTECHNOLOGY, INC. .
Fortuna: 4 M $ al 30/04/2024
Cargos activos de Nathan Hardy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director Financiero/CFO | 01/09/2018 | - |
Historial de carrera de Nathan Hardy
Antiguos cargos conocidos de Nathan Hardy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Director Financiero/CFO | 01/08/2017 | 01/06/2018 |
| AMGEN INC. | Director/Miembro de la Junta | 01/02/2007 | 01/08/2017 |
| Corporate Officer/Principal | 01/02/2007 | 01/08/2017 |
Formación de Nathan Hardy.
| University of Utah | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Nathan Hardy
- Experiencia
